Convatec Group PLC (LON:CTEC)

Market Cap	3.79B -32.8%
Revenue (ttm)	1.81B +6.6%
Net Income	130.03M -8.4%
EPS	0.06 -7.5%
Shares Out	1.95B
PE Ratio	30.36
Forward PE	13.20
Dividend	0.05 (2.78%)
Ex-Dividend Date	Apr 16, 2026

Volume	9,251,553
Open	196.00
Previous Close	194.00
Day's Range	193.50 - 196.90
52-Week Range	1.93 - 196.90
Beta	0.78
Analysts	Strong Buy
Price Target	299.25 (+53.54%)
Earnings Date	Aug 4, 2026

About Convatec Group

Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorect...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 10,910
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CTEC

Financial Performance

In 2025, Convatec Group's revenue was $2.44 billion, an increase of 6.55% compared to the previous year's $2.29 billion. Earnings were $175.00 million, a decrease of -8.38%.

Financial numbers in USD

Analyst Summary

According to 18 analysts, the average rating for CTEC stock is "Strong Buy." The 12-month stock price target is 299p, which is an increase of 53.54% from the latest price.

Price Target

299p

(53.54% upside)

Analyst Consensus: Strong Buy